Abstract
DR-BSI caused by Acitetobacter carbapenem resistant and 3 DR-BSI by P. aeruginosa carbapenem resistant. Median time to diagnosis for DR-Nosocomial BSI was 14 days (IQR), 7-35 days after hospital admission. For Gram-negative was 11 days (7.5-31.5) and for Grampositive 19 days (7-29). Only 31.7% of DR-BSI received appropriate initial empirical antimicrobial therapy versus 73.5% of non DR-BSI (p<0.001). More than one third (36.5%) of the episodes occur with significant systemic response (severe sepsis or septic shock). The crude mortality rate was 25.4 % (p<0.001). If the patient developed severe sepsis or septic shock crude mortality rose to 52.2%. Conclusion
Highlights
Bloodstream infections (BSI) are important causes of morbidity and mortality
A retrospective study was conducted about all BSI diagnosed in a secondary hospital during one year
Comparisons between groups were performed by means of the X2 test for categorical variables or analysis of variances (ANOVA) for continuous variables
Summary
Bloodstream infections (BSI) are important causes of morbidity and mortality. Most of all, when are caused by drug-resistant organisms (DR). P010: Bloodstream infections by drug-resistant organisms in a secondary hospital T Gimenez-Julvez1*, M Rodriguez-Aguirregabiria1, C Campelo2, E Palencia-Herrejon1, MJ Moreno Sanchez1, S de Juan-García1 From 2nd International Conference on Prevention and Infection Control (ICPIC 2013) Geneva, Switzerland. Introduction Bloodstream infections (BSI) are important causes of morbidity and mortality.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
